ArticleInternal medicine (Tokyo, Japan)2018

The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1.

Akio Miyasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.